Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24KALV&src=ctag" target="_blank"gt;$KALVlt;/agt;–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the…
Innovation from Kraig Labs R&D Team delivers next generation Spider Silk ANN ARBOR, Mich.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24KBLB&src=ctag" target="_blank"gt;$KBLBlt;/agt; lt;a href="https://twitter.com/hashtag/KBLB?src=hash" target="_blank"gt;#KBLBlt;/agt;–Kraig…
Innovation from Kraig Labs R&D Team delivers next generation Spider Silk ANN ARBOR, Mich.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24KBLB&src=ctag" target="_blank"gt;$KBLBlt;/agt; lt;a href="https://twitter.com/hashtag/KBLB?src=hash" target="_blank"gt;#KBLBlt;/agt;–Kraig…
Announces Additions of Dr. David N. Cook to Board of Directors and Dr. Boudewijn DeJonge to Leadership Team WALTHAM, Mass.–(BUSINESS…
Announces Additions of Dr. David N. Cook to Board of Directors and Dr. Boudewijn DeJonge to Leadership Team WALTHAM, Mass.–(BUSINESS…
Dose escalation phase of the study completed up to the maximum planned dose of 20 mg/kg without dose-limiting toxicities (DLT)…
Dose escalation phase of the study completed up to the maximum planned dose of 20 mg/kg without dose-limiting toxicities (DLT)…
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (“Acerus” or “the Company”) (TSX:ASP; OTCQB:ASPCF) announced today that it has signed a patent license agreement (the…
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (“Acerus” or “the Company”) (TSX:ASP; OTCQB:ASPCF) announced today that it has signed a patent license agreement (the…
TORONTO–(BUSINESS WIRE)–Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSXV: ATE, OTCQB: ATBPF), a leader in developing safer therapeutics for pain…